BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35505292)

  • 21. Analysis of polymorphism in the survivin gene promoter as a potential risk factor for head and neck cancers development.
    Kostić M; Nikolić N; Ilić B; Carkić J; Milenković S; Vukadinović M
    Srp Arh Celok Lek; 2013; 141(5-6):304-7. PubMed ID: 23858797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basal Cell Carcinoma in Gorlin's Patients: a Matter of Fibroblasts-Led Protumoral Microenvironment?
    Gache Y; Brellier F; Rouanet S; Al-Qaraghuli S; Goncalves-Maia M; Burty-Valin E; Barnay S; Scarzello S; Ruat M; Sevenet N; Avril MF; Magnaldo T
    PLoS One; 2015; 10(12):e0145369. PubMed ID: 26694869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
    Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM
    JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
    Liu-Smith F; Jia J; Zheng Y
    Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissecting the oncogenic potential of Gli2: deletion of an NH(2)-terminal fragment alters skin tumor phenotype.
    Sheng H; Goich S; Wang A; Grachtchouk M; Lowe L; Mo R; Lin K; de Sauvage FJ; Sasaki H; Hui CC; Dlugosz AA
    Cancer Res; 2002 Sep; 62(18):5308-16. PubMed ID: 12235001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase A activation inhibits oncogenic Sonic hedgehog signalling and suppresses basal cell carcinoma of the skin.
    Makinodan E; Marneros AG
    Exp Dermatol; 2012 Nov; 21(11):847-52. PubMed ID: 23163650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib.
    Hehlgans S; Booms P; Güllülü Ö; Sader R; Rödel C; Balermpas P; Rödel F; Ghanaati S
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of a sonic hedgehog signal transducer, hedgehog-interacting protein, by human basal cell carcinoma.
    Tojo M; Kiyosawa H; Iwatsuki K; Kaneko F
    Br J Dermatol; 2002 Jan; 146(1):69-73. PubMed ID: 11841368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis.
    So PL; Fujimoto MA; Epstein EH
    Mol Cancer Ther; 2008 May; 7(5):1275-84. PubMed ID: 18483315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel protein PTPIP51 is expressed in human keratinocyte carcinomas and their surrounding stroma.
    Koch P; Stenzinger A; Viard M; Märker D; Mayser P; Nilles M; Schreiner D; Steger K; Wimmer M
    J Cell Mol Med; 2008 Oct; 12(5B):2083-95. PubMed ID: 19012732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours.
    Dahmane N; Lee J; Robins P; Heller P; Ruiz i Altaba A
    Nature; 1997 Oct; 389(6653):876-81. PubMed ID: 9349822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-melanoma skin cancer: what drives tumor development and progression?
    Boukamp P
    Carcinogenesis; 2005 Oct; 26(10):1657-67. PubMed ID: 15905207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NAV3 copy number changes and target genes in basal and squamous cell cancers.
    Maliniemi P; Carlsson E; Kaukola A; Ovaska K; Niiranen K; Saksela O; Jeskanen L; Hautaniemi S; Ranki A
    Exp Dermatol; 2011 Nov; 20(11):926-31. PubMed ID: 21995814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin is associated with decreased risk of basal cell carcinoma: A whole-population case-control study from Iceland.
    Adalsteinsson JA; Muzumdar S; Waldman R; Wu R; Ratner D; Feng H; Ungar J; Silverberg JI; Olafsdottir GH; Kristjansson AK; Tryggvadottir L; Jonasson JG
    J Am Acad Dermatol; 2021 Jul; 85(1):56-61. PubMed ID: 33610593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers Found in the Tumor Interstitial Fluid may Help Explain the Differential Behavior Among Keratinocyte Carcinomas.
    Matas-Nadal C; Bech-Serra JJ; Gatius S; Gomez X; Ribes-Santolaria M; Guasch-Vallés M; Pedraza N; Casanova JM; de la Torre Gómez C; Garí E; Aguayo-Ortiz RS
    Mol Cell Proteomics; 2023 Jun; 22(6):100547. PubMed ID: 37059366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas.
    Kim AL; Back JH; Chaudhary SC; Zhu Y; Athar M; Bickers DR
    J Invest Dermatol; 2018 Aug; 138(8):1716-1725. PubMed ID: 29550418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative activation of hedgehog pathway induced by ultraviolet B radiation: preliminary study.
    Lesiak A; Sobolewska-Sztychny D; Bednarski IA; Wódz K; Sobjanek M; Woźniacka A; Narbutt J
    Clin Exp Dermatol; 2018 Jul; 43(5):518-524. PubMed ID: 29424103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the GLI2 oncogene and its isoforms in human basal cell carcinoma.
    Tojo M; Kiyosawa H; Iwatsuki K; Nakamura K; Kaneko F
    Br J Dermatol; 2003 May; 148(5):892-7. PubMed ID: 12786818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions.
    Urman NM; Mirza A; Atwood SX; Whitson RJ; Sarin KY; Tang JY; Oro AE
    PLoS One; 2016; 11(12):e0168031. PubMed ID: 28030567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlations between the Sonic Hedgehog pathway and basal cell carcinoma.
    Lupi O
    Int J Dermatol; 2007 Nov; 46(11):1113-7. PubMed ID: 17988327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.